US 6943161
Pyrimidine and triazine kinase inhibitors
expired A61PA61P35/04
Quick answer
US patent 6943161 (Pyrimidine and triazine kinase inhibitors) held by Pharmacopeia Drug Discovery, Inc. expires Mon Sep 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Pharmacopeia Drug Discovery, Inc.
- Grant date
- Tue Sep 13 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61P, A61P35/04